Karsten Berndt

Karsten Berndt has extensive work experience in the field of market access and health technology assessment. Karsten is currently working as a Regional Market Access Director at Veracyte, Inc. since April 2023. Prior to that, they served as a Health Technology Assessment Principal at HEOR from November 2022 to April 2023.

From September 2018 to December 2022, Karsten worked as an Independent Consultant for Market Access and Digitalisation, where they were responsible for international health economic modeling and value dossier writing for a prognostic test.

Earlier in their career, they held the position of Senior Manager Patient Access and Market Development at ACCURAY MEDICAL EQUIPMENT GmbH from March 2018 to August 2018. Karsten'sresponsibilities included developing market access strategies for cancer radiation therapies and preparing business cases and presentations for investors.

From November 2010 to February 2018, Karsten worked for Roche as a Senior Project Manager Health Technology Assessment. In this role, they directed Health Technology Assessment strategies, submitted dossiers to facilitate fact-based strategies, and led reimbursement decision processes. Karsten also represented the company during consultations with various HTA agencies.

Prior to Roche, they served as an Evaluator at Vereinigte IKK from July 2010 to October 2010. Before that, they were a Manager of Health Economics at Janssen-Cilag from 2007 to 2010.

Karsten's earlier experience includes working as a Consultant at IMS Health in 2006 and as a Consultant at IBM Global Services from 1999 to 2005.

Karsten Berndt's education history includes earning a degree in Political Economics (Diplom) from the University of Cologne. The specific start and end years are not provided for this degree. Additionally, Karsten Berndt obtained a Master of Science (MSc) in Epidemiology from the University of Mainz, although the start and end years for this degree are also not indicated.